A Clinical Trial on Efficacy and Safety for Lobaplatin and Gemcitabine in Combination With Docetaxel in the Second-line Treatments on Advanced Osteosarcoma

NCT02099396 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma

Interventions

DRUG: Docetaxel+lobaplatin
DRUG: Gemcitabine+lobaplatin

Sponsor

China Association of Osteosarcoma Chemotherapy